CN Patent

CN104130302B — 一种核苷药物的晶型及其制备方法

Assigned to Ruyuan Hec Pharm Co ltd · Expires 2017-02-15 · 9y expired

What this patent protects

本发明提供了索非布韦的一种新晶型及其制备方法，此晶型不含溶剂或结晶水，具有较好的溶解性和稳定性，能够用于制备制剂；通过将原料溶于乙醇等良溶剂中，然后加入异丙醚等反溶剂，能够获得此新晶型，方法简单。

USPTO Abstract

本发明提供了索非布韦的一种新晶型及其制备方法，此晶型不含溶剂或结晶水，具有较好的溶解性和稳定性，能够用于制备制剂；通过将原料溶于乙醇等良溶剂中，然后加入异丙醚等反溶剂，能够获得此新晶型，方法简单。

Drugs covered by this patent

Patent Metadata

Patent number: CN104130302B
Jurisdiction: CN
Classification: —
Expires: 2017-02-15
Drug substance claim: No
Drug product claim: No
Assignee: Ruyuan Hec Pharm Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.